BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 24694581)

  • 21. Bidirectional relationships between acute kidney injury and chronic kidney disease.
    Pannu N
    Curr Opin Nephrol Hypertens; 2013 May; 22(3):351-6. PubMed ID: 23508059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dyslipidemia in chronic kidney disease: are statins still indicated in reduction cardiovascular risk in patients on dialysis treatment?
    Scarpioni R; Ricardi M; Melfa L; Cristinelli L
    Cardiovasc Ther; 2010 Dec; 28(6):361-8. PubMed ID: 20553296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic kidney disease 10 years on: what have we learned?
    Taal MW
    Curr Opin Nephrol Hypertens; 2012 Nov; 21(6):607-11. PubMed ID: 23010759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.
    Parikh PB; Jeremias A; Naidu SS; Brener SJ; Lima F; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):352-7. PubMed ID: 22566286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repeat testing is essential when estimating chronic kidney disease prevalence and associated cardiovascular risk.
    Brook MO; Bottomley MJ; Mevada C; Svistunova A; Bielinska AM; James T; Kalachik A; Harden PN
    QJM; 2012 Mar; 105(3):247-55. PubMed ID: 21964723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Epidemiology of cardiovascular disease in CKD-MBD].
    Di Micco L; Mozzillo GR; Cianciaruso B
    G Ital Nefrol; 2009; 26 Suppl 49():S3-10. PubMed ID: 19941272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety of medical therapy in patients with chronic kidney disease and end-stage renal disease.
    Weir MR; Fink JC
    Curr Opin Nephrol Hypertens; 2014 May; 23(3):306-13. PubMed ID: 24670404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk stratification of cardiovascular events in patients at all stages of chronic kidney disease using myocardial perfusion SPECT.
    Yoda S; Nakanishi K; Tano A; Kasamaki Y; Kunimoto S; Matsumoto N; Sato Y; Hirayama A
    J Cardiol; 2012 Nov; 60(5):377-82. PubMed ID: 22890072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endothelial function and cardiovascular events in chronic kidney disease.
    Hirata Y; Sugiyama S; Yamamoto E; Matsuzawa Y; Akiyama E; Kusaka H; Fujisue K; Kurokawa H; Matsubara J; Sugamura K; Maeda H; Iwashita S; Jinnouchi H; Matsui K; Ogawa H
    Int J Cardiol; 2014 May; 173(3):481-6. PubMed ID: 24703800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular disease in chronic kidney disease.
    Saran AM; DuBose TD
    Ther Adv Cardiovasc Dis; 2008 Dec; 2(6):425-34. PubMed ID: 19124439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis and management of atherosclerotic cardiovascular disease in chronic kidney disease: a review.
    Mathew RO; Bangalore S; Lavelle MP; Pellikka PA; Sidhu MS; Boden WE; Asif A
    Kidney Int; 2017 Apr; 91(4):797-807. PubMed ID: 28040264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular disease in chronic kidney disease: risk factors, pathogenesis, and prevention.
    Ardhanari S; Alpert MA; Aggarwal K
    Adv Perit Dial; 2014; 30():40-53. PubMed ID: 25338421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Usefulness of risk grading system using albuminuria for predicting cardiovascular events and all-cause death in chronic kidney disease: a population-based prospective cohort study in Japan.
    Koeda Y; Tanaka F; Segawa T; Ohta M; Ohsawa M; Tanno K; Makita S; Ishibashi Y; Omama S; Onoda T; Nakamura M
    Int J Cardiol; 2014 Aug; 175(3):576-7. PubMed ID: 24874904
    [No Abstract]   [Full Text] [Related]  

  • 34. Arterial stiffness: a novel cardiovascular risk factor in kidney disease patients.
    Georgianos PI; Sarafidis PA; Lasaridis AN
    Curr Vasc Pharmacol; 2015; 13(2):229-38. PubMed ID: 24007427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How to balance risks and benefits in the management of CKD patients with coronary artery disease.
    Marenzi G; Cosentino N; Guastoni C
    J Nephrol; 2015 Aug; 28(4):403-13. PubMed ID: 25712237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effective CKD care in European countries: challenges and opportunities for health policy.
    Bello AK; Levin A; Manns BJ; Feehally J; Drueke T; Faruque L; Hemmelgarn BR; Kernahan C; Mann J; Klarenbach S; Remuzzi G; Tonelli M;
    Am J Kidney Dis; 2015 Jan; 65(1):15-25. PubMed ID: 25455091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Racial and survival paradoxes in chronic kidney disease.
    Kalantar-Zadeh K; Kovesdy CP; Derose SF; Horwich TB; Fonarow GC
    Nat Clin Pract Nephrol; 2007 Sep; 3(9):493-506. PubMed ID: 17717562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic kidney disease epidemic: How do we deal with it?
    Ng JK; Li PK
    Nephrology (Carlton); 2018 Oct; 23 Suppl 4():116-120. PubMed ID: 30298662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preventive Cardiology Update: Controversy, Consensus, and Future Promise.
    Berry JD
    Prog Cardiovasc Dis; 2015; 58(1):1-2. PubMed ID: 25968931
    [No Abstract]   [Full Text] [Related]  

  • 40. Kidney health for everyone everywhere - from prevention to detection and equitable access to care.
    Kam-Tao Li P; Garcia-Garcia G; Lui SF; Andreoli S; Wing-Shing Fung W; Hradsky A; Kumaraswami L; Liakopoulos V; Rakhimova Z; Saadi G; Strani L; Ulasi I; Kalantar-Zadeh K
    Arch Argent Pediatr; 2020 Apr; 118(2):e148. PubMed ID: 32199054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.